FGF21 and type 2 diabetes mellitus: FGF21-receptor agonists including PEGylated FGF21, Fc-FGF21 fusion, and FGF21-mimetic antibodies are currently under clinical investigations for its utility in type 2 diabetes and non-alcoholic steatohepatitis55.